Thekeytoearlyfludiagnosis
Actim®InfluenzaA&BdetectsanddifferentiatesbetweeninfluenzaAandBvirusantigensfromrespiratorysamplesinjust10minutes.
Influenzaisarespiratoryinfectioncausedbyinfluenzaviruses.Theseasonalfluepidemicsarecausedbytwomaintypesofinfluenzaviruses,AandB,whichinfectaround10%ofthepopulationeveryyear.Thesymptomsofinfluenzaaresimilartothesymptomscausedbyother,lesssevereviralinfections.However,itisimportanttodistinguishbetweeninfluenzaandcommoncold,sinceinfluenzaismorelikelytoresultinhospitalization,orevendeath.
ActimInfluenzaA&Bisdesignedtogivequickandreliableanswersonthespot.Earlydiagnosisofinfluenzaallowsantiviraltreatmenttoreducethedurationandseverityoftheillness.Inaddition,detectionofinfluenzareducesunnecessaryuseofantibioticsandhelpstotakepreventiveactionsintimetolimitthespreadoftheinfection.
- RapidlydetectsinfluenzaAandBfromvariousrespiratorysampletypes
- DetectsvariousinfluenzaAsubtypes,includingswineandavianflu
- Easy-to-useone-stepdipsticktest
- Givestestresultsatthebedsideinjust10minutes
- Nolaboratoryresourcesorsampleprocessingisneeded
- Thetestkitcontainsallnecessarymaterialsandcanbestoredatroomtemperature
- AvailablealsowithbothinfluenzaAandBpositivecontrolsforqualityassurance
TheActim®InfluenzaA&Brapidtestisbasedonhighlyspecificmonoclonalantibodiesthatdetectnucleoproteinofthevirus.Thisistheinternalpartofthevirusthatisnotsubjecttoannualstructuralchanges.ActimInfluenzaA&Bisspecifictoinfluenzaanddoesnotdetectotherrespiratoryviruses,suchasadenovirus,rapidrespiratorysyncytialvirus,orrhinovirus.ItdetectswiderangeofInfluenzaAsubtypes,includingH5N3,H7N3,H9N2,H5N1(“avianflu”),andH1N1v(“swineflu”).
ABOUTINFLUENZAVIRUSNUCLEOPROTEIN
- NucleoproteinencapsidatestheRNAgenomeofthevirus
- Conservedacrossinfluenzavirussubtypes
ActimInfluenzaA&Bcanbeusedforvariousrespiratorysamples:nasalaspirates,nasalwashes,orswabs,anditissuitableforviscoussamplesaswell.
HowActimInfluenzaA&Bhelps
Influenzadiagnosticstestshaveacrucialroleindetectingindividualcasesandmonitoringthespreadofdifferentviralstrains.However,manyavailabletestsmethodsaretimeconsumingandrequirelaboratoryequipmentandtrainedlaboratorystaff.Actim®InfluenzaA&Benablesfastandeasyinfluenzatesting.
Antiviraldrugsmayeasetheseverityofthesymptomsandshortenthedurationoftheinfection.Forriskgroups,antiviralsmaypreventthemoresevereformofinfluenzaandtheneedofhospitalization.However,antiviralsworkbest,whenthetreatmentisstartedattheearlyonsetofthesymptoms(usuallywithin2days).Therefore,theimportanceofearlydetectionofinfluenzaiscrucial. ApositiveresultfromActimInfluenzaA&Bhelpsdecision-makingandpromotesontimetreatment.
ActimInfluenzaA&Bdiagnosesinfluenzawithoutdelay
- Reliabletestingonthespot
- Immediateaccesstoresults
- Noneedforlaboratoryfacilities
- Enablesearlystartofantiviraltreatment
- Helpstofollowthebeginninganddevelopmentoftheinfluenzaepidemic
HowtouseActimInfluenzaA&B
Thetestkitcontainsallnecessarymaterialsandcanbestoredatroomtemperature:2–30°C.
Collectarespiratorysample
Nasal/nasopharyngealswab,nasalwash/aspirate.
Extractthesamplefornasal/nasopharyngealswab
Dispense12dropsofSwabExtractionBufferintothetesttube.
Placetheswabintothetesttubeandswirlaroundforabout10seconds.Presstheswabagainstthewallofthetubeandremoveitfromthetube.
Extractthesamplefornasalwash/aspirate:
Dispense3dropsofExtractionBufferintothetesttube.
Mixthesolutionswell.
Activatethetest
PlacetheyellowdipareaintothetesttubewithextractedsampleandleaveitthereuntilreADIng.
Interpretresults
ApositiveresultcanbereadassoonasitbecomesvisIBLe.Onebluelineinthelowerpartoftheresultarea=influenzaApositive,Onebluelineinthemiddlepartoftheresultarea=influenzaBpositive,Twobluelinesintheresultarea=influenzaAandBpositive.
Anegativeresultshouldbeconfirmedat10minutes.Onlyablackcontrollineisvisible=influenzavirusnotdetected,furtherinvestigationneeded.
HowtoorderActimInfluenzaA&B
Actim®InfluenzaA&Btestkitcontains20testsanditisavailablewithorwithoutcontrols.Alltestkitscontain:
- Dipsticks(individuallypacked)
- SwabExtractionBuffer
- ExtractionBuffer
- Swabs
- Testtubes
- Briefinstructions
- Instructionsforuse
Inaddition,ActimInfluenzaA&Btestkit32836ETACcontainsexternalinfluenzacontrolswabs:onecontrolswabeachofPositiveControlAandPositiveControlB.
Orderinginformation
- ActimInfluenzaA&B20testkitwithcontrols,ref:32836ETAC
- ActimInfluenzaA&B20testkit,ref:32837ETAC
ActimInfluenzaA&Bbrochures
DownloadActimInfluenzaA&Bbrochure,English
DownloadActimInfluenzaA&Bbrochure,Finnish
ActimInfluenzaA&Binstructionsforuse
DownloadActimInfluenzaA&BtestIFU
DownloadActimInfluenzaA&Btestbriefinstructions
Technicaldocuments
| DeclarationofConformityActimInfluenzaA&B | Download |
| MSDSActimInfluenzaA&B | Download |
| ISO13485:2016certificate | Download |
| ISO13485:2003CMDCAScertificate | Download |
Medix Biochemica，一家享誉世界的芬兰公司，三十余年来一直专注于体外诊断相关原料、尤其是体外诊断试剂核心组份、如单克隆抗体、抗原等原料的供应，涵盖了炎症、激素、肿瘤、甲状腺、心血管、糖尿病、骨代谢、肾损伤、传染病、血清学等领域。 自1994年起公司所有产品均通过体外培养技术生产，并遵循ISO13485以及FDA质量管理条例(QSR)。通过体外培养生产工艺及生产过程中的数百个质量控制点，有效避免了小鼠腹水的个体差异及非特异性蛋白导致的抗体批间差，批产量达200克、质量稳定可靠，并因此成为世界范围内体外诊断用单克隆抗体的首选供应商之一。 为了更贴近国内企业，更好地理解和满足国内企业的需要、支持国内IVD行业的发展，Medix Biochemica于2016年2月29日成立中国全资子公司---上海墨迪斯医疗技术有限公司，并于2017年8月在上海成立应用实验室，这也是外资IVD原料企业在国内的第一个应用实验室。 公司将立足中国，逐步进行本地化合作、研发、和生产，真正做到植根国内，为国内体外诊断试剂的发展和国产化添砖加瓦。
本网站将在规定时间内给予删除等相关处理。
